CHARLOTTESVILLE, Va. (WVIR) -A new study led by UVA Health is changing how doctors may treat sepsis in parts of Africa, after ...

A new drug developed by Australian researchers has shown promising results in reducing sepsis in a Phase II clinical trial involving 180 patients. The carbohydrate-based treatment works by calming a ...

A new experimental treatment has shown encouraging results in a recent clinical trial, offering new hope against one of medicine’s most challenging conditions.

Griffith University researchers may have unlocked the secret to treating sepsis, with a Phase II clinical trial in China successfully concluding with promising results. Subscribe to our newsletter for ...

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...

VIRGINIA (WVNS) – A medical study out of the University of Virginia could change the way physicians treat a common but deadly condition. West Virginia patients showed some of the highest sepsis ...

Prior to February 2024, limited therapeutics were available to treat sepsis, a life threatening organ dysfunction caused by a dysregulated host response to infection. Now, a new, commercially viable ...

A University of Virginia-led team of researchers has made a discovery that may change sepsis treatment for patients in Africa. Over the course of five years, the researchers studied patients with ...

Of all the life-threatening conditions hospitals battle on a daily basis, sepsis is a particularly fickle beast. Despite the difficulties associated with diagnosing this complication, healthcare ...

According to the Centers for Disease Control and Prevention, there are more than 1.7 million cases of sepsis every year, leading to 300,000 annual deaths. "Sepsis is a potentially lethal condition; ...

Sepsis, a potentially-life threatening complication of an infection, affects roughly 750,000 Americans each year and costs more than $22,000 per patient to treat, according to Verras. Verras analyzed ...

In adults hospitalized with suspected sepsis, piperacillin-tazobactam was associated with a higher mortality rate and increased duration in organ dysfunction compared with cefepime, according to a ...